Literature DB >> 9525693

Molecular and cell biology of TGF-beta.

A B Roberts1.   

Abstract

The TGF-betas are a remarkable set of peptides consisting of three highly homologous isoforms, TGF-beta 1, 2, and 3. Distinguished initially for their ability to inhibit the growth of most epithelial and hematopoietic cells and to regulate the production of extracellular matrix by mesenchymal cells, these peptides are now known to act via autocrine, paracrine, and endocrine modes to control a wide variety of developmental processes and to play key roles in the pathogenesis of many diseases including especially fibrotic diseases, parasitic diseases, autoimmune diseases, and carcinogenesis. The activity of these peptides is under tight control by processes including regulation of the expression of the isoforms and their receptors and of the trafficking and activation of their latent forms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525693     DOI: 10.1159/000057358

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  91 in total

1.  An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system.

Authors:  D E Mosedale; D J Grainger
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair.

Authors:  C Soo; F Y Hu; X Zhang; Y Wang; S R Beanes; H P Lorenz; M H Hedrick; R J Mackool; A Plaas; S J Kim; M T Longaker; E Freymiller; K Ting
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.

Authors:  Trevor A Petrel; Robert W Brueggemeier
Journal:  J Cell Biochem       Date:  2003-01-01       Impact factor: 4.429

Review 4.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

5.  Bcr-Abl activates the AKT/Fox O3 signalling pathway to restrict transforming growth factor-beta-mediated cytostatic signals.

Authors:  Azeddine Atfi; Lucile Abécassis; Marie-Francoise Bourgeade
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

6.  A mechanism by which dietary trans fats cause atherosclerosis.

Authors:  Chun-Lin Chen; Laura H Tetri; Brent A Neuschwander-Tetri; Shuan Shian Huang; Jung San Huang
Journal:  J Nutr Biochem       Date:  2010-10-30       Impact factor: 6.048

7.  Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.

Authors:  Michiya Yasutome; Jason Gunn; Murray Korc
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

8.  Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome.

Authors:  Zehra Berberoglu; Aynur Aktas; Yasemin Fidan; Ayse Canan Yazici; Yalcin Aral
Journal:  J Bone Miner Metab       Date:  2014-01-16       Impact factor: 2.626

9.  Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis.

Authors:  Chun-Lin Chen; I-Hua Liu; Steven J Fliesler; Xianlin Han; Shuan Shian Huang; Jung San Huang
Journal:  J Cell Sci       Date:  2007-09-18       Impact factor: 5.285

10.  Demonstration of the interaction of transforming growth factor beta 2 and type X collagen using a modified tandem affinity purification tag.

Authors:  Maozhou Yang; Xinli Wang; Liang Zhang; Chiyang Yu; Bingbing Zhang; William Cole; Greg Cavey; Paula Davidson; Gary Gibson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-10-15       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.